Clarissa Morales ,
-
FDA Takes Up Bid to Expand Gazyva for Lupus After New Phase 3 Trial
The FDA has accepted a filing to expand Gazyva for systemic lupus erythematosus, but the IV drug is not approved for broader lupus in the U.S. yet.
-
Why the FDA’s trial-results push matters for patients and readers
The FDA is pressing more than 2,200 sponsors and researchers to post required clinical trial results to ClinicalTrials.gov. For patients and readers, the issue is simple: missing results can distort what we think works, what does not, and how safe a medical product really is.
-
Echinacea and Cold Prevention: Myth vs. Evidence-Based Facts
In conclusion, while Echinacea shows promise, more research is needed.
-
Transmission and Prevention of Communicable Diseases
Communicable diseases are a major health concern all over the world. They can be life-threatening and require prompt and effective treatment. In this article, we will discuss the transmission of…
